The present invention relates to transgenic animals, as well as
compositions and methods relating to the characterization of gene
function. Specifically, the present invention provides transgenic mice
comprising disruptions in genes, which are useful as models for disease
and for identifying agents that modulate gene expression and gene
function, and as potential treatments for various disease states and
disease conditions.